Tetrahydroepiberberine

CAS No. 38853-67-7

Tetrahydroepiberberine( —— )

Catalog No. M21500 CAS No. 38853-67-7

Tetrahydroepiberberine an isoquinoline alkaloid has antifungal and selective inhibition against the PI-3 virus activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 78 In Stock
10MG 129 In Stock
25MG 221 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tetrahydroepiberberine
  • Note
    Research use only, not for human use.
  • Brief Description
    Tetrahydroepiberberine an isoquinoline alkaloid has antifungal and selective inhibition against the PI-3 virus activities.
  • Description
    Tetrahydroepiberberine an isoquinoline alkaloid has antifungal and selective inhibition against the PI-3 virus activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Antifungal
  • Recptor
    Antifungal| PI-3 virus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    38853-67-7
  • Formula Weight
    339.4
  • Molecular Formula
    C20H21NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20.83 mg/mL (61.37 mM)
  • SMILES
    COc1cc(CCN2C3Cc4ccc5OCOc5c4C2)c3cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Niu X et al. Simultaneous quantification of 11 isoquinoline alkaloids in Corydalis impatiens (Pall.) Fisch by HPLC. J Sep Sci. 2013 Jul;36(13):2090-5.
molnova catalog
related products
  • Asebogenin

    Asebogenin is a compound fractionated from Salvia miltiorrhiza with antifungal activity, inhibition of GPVI-induced platelet reactions, and inhibition of NET formation induced by pro-inflammatory stimuli.

  • Butoconazole

    Butoconazole is an imidazole antifungal agentButoconazole is particularly effective against in vivo Candida albicans infections (mice), maintaining good activity down to 0.25% formulation strength and showing unusually low reinfection rates after treatment is ended.

  • APX2039

    APX2039 is an orally active fungal Gwt1 enzyme inhibitor and a prodrug of the novel Gwt2096 inhibitor APX1.APX2039 exhibits potent anti-Kryptococcal activity against C. neoformans and C. gattii.